[#item_full_content]

[#item_full_content]

[#item_full_content]

GRO Biosciences Closes $60M Series B Financing Co-Led by Atlas Venture and Access Biotechnology

[#item_full_content]BOSTON–(BUSINESS WIRE)–GRO Biosciences Inc. (“GRObio”), a biotechnology company leveraging synthetic biology to expand the amino acid…

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]